z-logo
Premium
Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti‐CD22 therapies. AKA not all anti‐CD22 antibodies are created equal
Author(s) -
AconLaws Malcolm,
Bayerl Michael G.,
Ehman Christopher,
Malysz Jozef,
Boyer Cinda
Publication year - 2011
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22130
Subject(s) - cd22 , calicheamicin , medicine , b cell , immunology , antibody

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom